Micro-tweezers and Force Microscopy Techniques for Single-Cell Mechanobiological Analysis See

Inhibition of lysyl oxidase-like 2 overcomes adhesion-dependent drug resistance in the collagen-enriched liver cancer microenvironment See

Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor types (Nature Medicine, (2022), 28, 7, (1421-1431), 10.1038/s41591-022-01799-y) See

A T cell resilience model associated with response to immunotherapy in multiple tumor types See

Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma See

Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism (Oncogene, (2021), 40, 6, (1147-1161), 10.1038/s41388-020-01593-5) See

Nanotopographic Regulation of Human Mesenchymal Stem Cell Osteogenesis See

Exploring treatment options in cancer: Tumor treatment strategies See

Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes See

Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis See

Evaluating Virtual Contrast-Enhanced Magnetic Resonance Imaging in Nasopharyngeal Carcinoma Radiation Therapy: A Retrospective Analysis for Primary Gross Tumor Delineation See

First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration See

International recommendations on postoperative management for potentially resectable locally recurrent nasopharyngeal carcinoma See

FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma See

HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer See

3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip See

Gut microbiome regulates immunotherapy response through systemic immune environment in patients with hepatocellular carcinoma See

Molecular detection of circulating cancer cells with cancer stem cell or mesenchymal characteristics in esophageal squamous cell carcinoma (ESCC) See

Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer See